Getting My Raw Materials To Work
“The existing condition has exposed some structural weaknesses during the EU’s medicines supply chain as well as a high dependence on non-EU countries for active pharmaceutical ingredients,” Kyriakides explained. She suggested that supply chain difficulties be addressed in an EU ph